Rapid Acting Antidepressants

Herausgegeben:Duman, Ronald S.; Krystal, John H.

• Gebundenes Buch

Produktbeschreibung

The Advances in Pharmacology series presents a variety of chapters from the best authors in the field.

Produktdetails

• Advances in Pharmacology Volume 89
• Verlag: Academic Press / Elsevier Science & Technology
• Artikelnr. des Verlages: S1054-3589(20)X0004-4
• Englisch
• Abmessung: 22mm x 152mm x 229mm
• Gewicht: 770g
• ISBN-13: 9780128201893
• Artikelnr.: 67578758

Autorenporträt

Ronald Duman is at Yale University School of Medicine, CT, USA

Inhaltsangabe

Part I - Neurobiology of ketamine effects

1. Effects of ketamine and other rapidly acting antidepressants on hippocampal excitatory and inhibitory transmission


Allie J. Widman and Lori L. McMahon




2. Antidepressant mechanisms of ketamine: Focus on GABAergic inhibition


Bernhard Luscher, Mengyang Feng and Sarah J. Jefferson




3. The role of eEF2 kinase in the rapid antidepressant actions of ketamine


Kanzo Suzuki and Lisa M. Monteggia



Part II - The rapid therapeutic effects of ketamine


4. Clinical overview of NMDA-R antagonists and clinical practice


Pasha A. Davoudian and Samuel T. Wilkinson




5. Ketamine for depression clinical issues


Syed Z. Iqbal and Sanjay J. Mathew




6. Chronic stress pathology and ketamine-induced alterations in functional connectivity in major depressive disorder: An abridged review of the clinical evidence


Lynnette A. Averill, Samar Fouda, James W. Murrough and Chadi G. Abdallah




7. Neurobiological biomarkers of response to ketamine


Bashkim Kadriu, Elizabeth D. Ballard, Ioline D. Henter, Stephen Murata, Nimesha Gerlus and Carlos A. Zarate Jr




8. Relapse prevention in treatment resistant major depressive disorder with rapid-acting antidepressants


Jaskaran B. Singh, Maggie Fedgchin, Ella J. Daly and Wayne C. Drevets




9. The emergence of ketamine as a novel treatment for posttraumatic stress disorder


Adriana Feder, Sarah B. Rutter, Daniela Schille and Dennis S. Charney



Part III - Novel rapid-acting antidepressant mechanisms related to ketamine


10. mGlu2/3 receptor as a novel target for rapid acting antidepressants


Shigeyuki Chaki




11. Involvement of muscarinic receptor mechanisms in antidepressant drug action


Jeffrey M. Witkin, Jodi L. Smith, Lalit K. Golani, Emily A. Brooks and Anna E. Martin




12. The antidepressant efficacy of the muscarinic antagonist scopolamine: Past findings and future directions

Wayne C. Drevets, Anindya Bhattacharya and Maura L. Furey